Note of clarification regarding data about the association between the interleukin-1β ↿1T>C polymorphism and breast cancer risk

详细信息    查看全文

• 作者：Yadong Wang ; Yan Wang ; Li Li
• 关键词：IL ; 1β ; Polymorphism ; Breast cancer ; Risk ; Meta ; analysis
• 刊名：Breast Cancer Research and Treatment
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：155
• 期：3
• 页码：415-417
• 全文大小：353 KB
• 参考文献：1.Liu X, Wang Z, Yu J, Lei G, Wang S (2010) Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis. Breast Cancer Res Treat 124:821–825CrossRef PubMed
  2.Liu J, Zhai X, Jin G, Hu Z, Wang S, Wang X, Qin J, Gao J, Ma H, Wei Q, Shen H (2006) Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer 118:2554–2558CrossRef PubMed
  3.Akisik E, Dalay N (2007) Functional polymorphism of thymidylate synthase, but not of the COMT and IL-1B genes, is associated with breast cancer. J Clin Lab Anal 21:97–102CrossRef PubMed
  
• 作者单位：Yadong Wang (1) (2)
  Yan Wang (1)
  Li Li (1)
  
  1. Department of Toxicology, Henan Center for Disease Control and Prevention, No. 105 of South Nongye Road, Zhengzhou, 450016, China
  2. Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Xinxiang, 453003, China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  
• 出版者：Springer Netherlands
• ISSN：1573-7217

文摘